We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FSP
2176
Franklin Street Properties
FSP
$46.8M
| $2.91M | ﹤0.01% |
570,838
+40,432
| +8% | +$214K |
|
2177
MGP Ingredients
MGPI
$375M
| $2.9M | ﹤0.01% |
79,146
+9,225
| +13% | +$330K |
|
2178
Virgin Galactic
SPCE
$398M
| $2.9M | ﹤0.01% |
+9,417
| New | +$3.09M |
|
2179
WisdomTree
WT
$3.22B
| $2.9M | ﹤0.01% |
835,361
+264,440
| +46% | +$803K |
|
|
HARP
2180
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $2.9M | ﹤0.01% |
17,459
+2,836
| +19% | +$442K |
|
2181
Griffon
GFF
$4.86B
| $2.88M | ﹤0.01% |
155,352
-56,926
| -27% | -$927K |
|
2182
Canadian National Railway
CNI
$76.6B
| $2.86M | ﹤0.01% |
+32,320
| New | +$2.69M |
|
|
BRG
2183
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
| $2.86M | ﹤0.01% |
354,148
-157,187
| -31% | -$1.04M |
|
2184
The Greenbrier Companies
GBX
$1.46B
| $2.85M | ﹤0.01% |
125,504
-1,696
| -1% | -$33K |
|
2185
Live Oak Bancshares
LOB
$1.97B
| $2.85M | ﹤0.01% |
196,553
+43,515
| +28% | +$590K |
|
2186
Scansource
SCSC
$1.12B
| $2.85M | ﹤0.01% |
118,081
+18,082
| +18% | +$428K |
|
2187
St. Joe Company
JOE
$3.83B
| $2.84M | ﹤0.01% |
146,020
-13,981
| -9% | -$258K |
|
2188
Korro Bio
KRRO
$195M
| $2.83M | ﹤0.01% |
+2,432
| New | +$2.2M |
|
|
CCF
2189
DELISTED
Chase Corporation
CCF
| $2.82M | ﹤0.01% |
27,555
-747
| -3% | -$69.8K |
|
2190
MBIA
MBI
$260M
| $2.82M | ﹤0.01% |
389,099
-297,722
| -43% | -$2.16M |
|
2191
Tanger
SKT
$4.52B
| $2.8M | ﹤0.01% |
392,603
-36,787
| -9% | -$243K |
|
2192
PetMed Express
PETS
$42.3M
| $2.79M | ﹤0.01% |
78,429
+555
| +0.7% | +$19.3K |
|
|
KRA
2193
DELISTED
Kraton Corporation
KRA
| $2.79M | ﹤0.01% |
161,283
-130,736
| -45% | -$1.77M |
|
|
KE
2194
Kimball Electronics
KE
$628M
| $2.78M | ﹤0.01% |
205,565
-18,998
| -8% | -$244K |
|
2195
Precigen
PGEN
$2.59B
| $2.78M | ﹤0.01% |
557,498
+72,613
| +15% | +$247K |
|
2196
CNA Financial
CNA
$14.1B
| $2.78M | ﹤0.01% |
86,480
-18,535
| -18% | -$571K |
|
2197
Unisys
UIS
$217M
| $2.78M | ﹤0.01% |
254,381
-102,524
| -29% | -$1.19M |
|
2198
KALA BIO
KALA
$14.5M
| $2.77M | ﹤0.01% |
105
+33
| +46% | +$935K |
|
2199
York Water
YORW
$514M
| $2.76M | ﹤0.01% |
57,519
+3,093
| +6% | +$134K |
|
2200
Crinetics Pharmaceuticals
CRNX
$8.92B
| $2.74M | ﹤0.01% |
156,572
+128,522
| +458% | +$2.19M |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.